Riskpilot← Back to searchSign inGet full accessWASA TANDKLINIK AB
ABActiveOrg 5567645808Tegnérgatan 8 BvDental practice care activities · NACE 8623Est. 20087 employees
Revenue 2024
SEK 17,1M
-6% vs 2023
EBITDA margin
16.0%
-40% vs 2023
Equity ratio
30.6%
Financial strength
Net profit 2024
SEK 2,3M
-29% vs 2023
| Revenue | SEK 17,1M | -6% |
| EBITDA | SEK 2,7M | -40% |
| Net profit | SEK 2,3M | -29% |
| Total assets | SEK 8,4M | -10% |
| Equity | SEK 2,6M | -26% |
| Employees | 7 | — |
Legal name
WASA TANDKLINIK AB
Org number
5567645808
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
27 augusti 2008
Share capital
SEK 100 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva tandvårdsklinik samt därmed förenlig verksamhet.
Address
Tegnérgatan 8 Bv
Email
maryam@wasatandklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 11 239 | 13 615 | 14 448 | 18 133 | 17 075 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 763 | 3 935 | 2 986 | 4 570 | 2 733 |
| Depreciation & amort. | −587 | −329 | −336 | −480 | −449 |
| EBIT | 3 176 | 3 606 | 2 650 | 4 090 | 2 284 |
| Net financials | −3 | −3 | −2 | 7 | 250 |
| Profit before tax | 2 889 | 4 473 | 2 648 | 4 123 | 2 938 |
| Tax | −637 | −966 | −577 | −883 | −649 |
| Net profit | 2 252 | 3 507 | 2 071 | 3 240 | 2 289 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 347 | 8 277 | 7 257 | 9 297 | 8 350 |
| Equity | 3 046 | 3 653 | 2 224 | 3 464 | 2 553 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 398 | 609 | 1 017 | 1 843 | 2 211 |
| Total debt | 398 | 609 | 1 017 | 1 843 | 2 211 |
EBITDA margin
16.0%
This company
15.8%
Market median
+1% vs market
20202024
Equity ratio
30.6%
This company
38.2%
Market median
+20% vs market
20202024
Return on equity
89.7%
This company
18.4%
Market median
+388% vs market
20202024
Net profit margin
13.4%
This company
8.1%
Market median
+65% vs market
20202024
Asset turnover
2.04×
This company
1.12×
Market median
+82% vs market
20202024
Debt / equity
2.27×
This company
0.62×
Market median
-266% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NO | Audit | 2024 |
| Former (1) | ||
TG | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Maryam Pourmousa AB
WASA TANDKLINIK AB Board members of WASA TANDKLINIK AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Olof Gustaf Kannö | Audit | 0 companies |
| Thomas Gustaf Blomkvist | Audit | 0 companies |
| Seyedeh Awa Dehghani Bonaki | Deputy Board Member | 0 companies |
| Maryam Pourmousa Arabani | Board of Directors | 0 companies |